Sporos is led by a proven and seasoned management team. Collectively, they have overseen the research, development, and regulatory approval of many pharmaceutical products.
Seasoned leaders provide support to all operated portfolio programs as acting executives guiding scientific, clinical, regulatory, financial and operating oversight.
Stephen Rubino, Ph.D.
Chief Executive Officer
Eric Rowinsky, M.D.
Consulting Chief Medical Officer
Sharon Shacham, Ph.D.
Consulting Lead Scientist
Small Molecules, Innovation & Technology
Florian Muller, Ph.D.
Senior Director, Cancer Biology
Benjamin Stein
Senior Director, Controller
Rachel Humphrey, M.D.
CEO, Normunity
Alex Cranberg, M.B.A.
Chairman & Founder, Aspect Energy
Stephen Rubino, Ph.D.
CEO, Sporos Bioventures
Harold Levy
Co-CIO, Iridian Asset Management
Peter Feinberg
Founding Partner, Boxcar Partners
Joseph Kekst
Founding Partner, Boxcar Partners